Australian researchers have manufactured a living blood vessel
A blood vessel isn’t just a simple tube. Researchers at the University of Sydney have developed an implant capable of mimicking its complexities.
Flu and RSV can fuse into a new kind of virus
In a new discovery, researchers at the University of Glasgow have observed hybrid viruses capable of infecting lung cells in the lab.
New smart contact lens monitors for glaucoma 24/7
Purdue researchers have created a smart, soft contact lens that can test for eye pressure, a key indicator of glaucoma, 24 hours a day.
Experimental “FLASH” cancer treatment aces first human trial
The first-in-human trial of FLASH radiotherapy found the experimental cancer treatment to be safe and effective.
Withdrawal symptoms from antidepressants can last over a year
A scientific review found that withdrawal symptoms from antidepressants and antipsychotics can last for over a year.
Merck pays Moderna $250m for personalized cancer vaccine
Pharma giant Merck has paid Moderna $250 million to co-develop and commercialize its promising mRNA-based personalized cancer vaccine.
Scientists discover slug that can decapitate itself, grow new body
Scientists observed two species of sea slug that were able to self-decapitate, survive for weeks without organs, and regenerate new bodies.
Deep brain stimulation can be life-altering for OCD sufferers when other treatment options fall short
Deep brain stimulation relies on thin electrodes implanted deep in the brain that deliver electrical currents. Could it treat OCD?
New vaccine prevents 94% of severe RSV cases
UK drugmaker GSK’s RSV vaccine was nearly 95% effective at preventing severe infection in a phase 3 trial of older adults.